Amazon Pharmacy is now offering Eli Lilly's Foundayo, a recently approved once-daily oral GLP-1 for adults with obesity or overweight with related health conditions. The listing expands patient access via a major retail pharmacy channel and may modestly benefit distribution reach for the drug, but is unlikely to meaningfully move Amazon or Eli Lilly shares in the near term.
Amazon Pharmacy is now offering Eli Lilly's Foundayo, a recently approved once-daily oral GLP-1 for adults with obesity or overweight with related health conditions. The listing expands patient access via a major retail pharmacy channel and may modestly benefit distribution reach for the drug, but is unlikely to meaningfully move Amazon or Eli Lilly shares in the near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
